A glucolipotoxic environment, similar to that observed in type 2 diabetes, is known to inhibit insulin biogenesis [8, 53], vesicle budding, protein trafficking and ER lipid raft formation [54, 55]. Here, INS is linked to type 2 diabetes mellitus.